share_log

CNS Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Evans Carl Anthony

SEC ·  Apr 10, 2024 21:53
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more